Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines this year, the Covid-19 pandemic remains a threat to…
27/08/2021 - 7 minutes
BioNTech
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
25/05/2021 - 6 minutes
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
11/01/2021 - 11 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
22/12/2020 - 5 minutes
Covid-19 Pandemic Drives RNA Therapeutics into the Mainstream
With messenger RNA being pushed to the market in record time and Alnylam’s historic approval…
02/12/2020 - 8 minutes
mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine
The field of messenger RNA therapeutics is flying high as BioNTech and Pfizer conclude a…
19/11/2020 - 6 minutes
Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise
A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer…
03/07/2020 - 3 minutes
Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans
Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner…
29/04/2020 - 5 minutes
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
30/03/2020 - 7 minutes
BioNTech Expands Cancer Portfolio With US Biotech Acquisition
German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal…
16/01/2020 - 2 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
06/01/2020 - 2 minutes
